In particular, ISPD mutations appear to be responsible for a relatively high proportion of dystroglycanopathies within the most severe clinical spectrum [13, 14, 17], although they have also been described in a few LGMD cases [28–30]. The gene discussed is CRPPA; the disease is limb-girdle muscular dystrophy.